JJ Open Meeting: May 9, 2022
Open Meeting Notification — Proposed LCD(s) Released for Comment
A/B MAC LCDs
- Allogeneic Hematopoietic Cell Transplantation for primary refractory or relapsed Hodgkin's and non-Hodgkin's lymphoma with B-cell or T-cell origin DL39270
- Bone Mass Measurement DL39268
- Cognitive Assessment and Care Plan Service DL39266
- CT of the Abdomen and Pelvis DL34415
- Hyaluronic Acid Injections for Knee Osteoarthritis DL39260
- Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compressions Fracture (VCF) DL38737
- Surgical Treatment of Nails DL39258
- Upper Gastrointestinal Endoscopy and Visualization DL34434
The Centers for Medicare & Medicaid Services (CMS) assigned Palmetto GBA the task of developing local coverage determinations (LCDs) for processing and reviewing Medicare claims for Jurisdictions J and M. These LCDs can be found utilizing the Proposed LCD by Contractor Report on the Medicare Coverage Database. The entire LCD and related billing and coding article should be completely reviewed prior to the preparation of comments.
Palmetto GBA is soliciting comments on these proposed LCDs from physicians, manufacturers, suppliers and other professionals involved in the ordering and/or provisioning of these items. Other stakeholder comments are also welcomed. For medical professionals, we ask that you distribute these proposed LCDs to selected members of your organization for review and comment. If you disagree with any aspect of an LCD, you should be very specific in your comment and, if possible, offer an alternative. You should provide a clinical rationale for your position, including references from published clinical literature (e.g., peer-reviewed journals, clinical society guidelines, etc.). Submission of full-text literature supporting your position is strongly encouraged. We ask for a written response, regardless of your agreement or disagreement.
The open meeting was held via teleconference on May 9, 2022.
Meeting Materials
Important reminder: Providers and/or suppliers are cautioned not to make any changes based upon the information contained in a proposed LCD. Proposed LCDs are often substantially revised based upon the comments received. Revisions will be considered once all comments have been reviewed. The final LCD will be published in the CMS Medicare Coverage Database and on individual contractors’ websites, allowing for a minimum of 45-days’ public notice before the LCD becomes effective.
Refer to each contractor’s website for additional information about LCD development and for copies of the draft LCDs.